Dave Ricks — SPARQNOW

At-a-Glance

Serves as Chair and Chief Executive Officer of Eli Lilly and Company, assuming both roles in 2017.
Has over 25 years of experience at Eli Lilly and Company, including marketing, sales, drug development, and international operations.
Serves on the board of Adobe and the Purdue University Board of Trustees.
Is the immediate past chair of the board of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Received a salary package of $29.2 million for 2024 as CEO and chair of Eli Lilly and Company.
Supports permanent lower tax rates in the United States, including 15% for business production, and an extension of the Tax Cuts and Jobs Act.
Earned a Bachelor of Science from Purdue University in 1990 and a Master of Business Administration from Indiana University's Kelley School of Business in 1996.

Biography

David A. Ricks is the Chair and Chief Executive Officer of Eli Lilly and Company, a position he has held since 2017. He joined Eli Lilly and Company over 25 years ago, gaining experience across various functions including marketing, sales, drug development, and international operations. He became CEO in January 2017 and was elected chair of the company’s board of directors in June 2017.

Ricks serves on the board of Adobe and is a member of the Purdue University Board of Trustees.